Stay Informed
Global Health Technologies Coalition

advancing innovation to save lives

GHTC announces 2020 awards

GHTC honored Senators John Boozman and Patty Murray for their leadership in supporting global health R&D with its 2020 Innovating for Impact Awards, which celebrate the US policymakers and partnerships driving global health innovation. GHTC also recognized the CARB-X partnership for antibiotic research.

Learn more

New report examines COVID-19 impacts

GHTC released a new report exploring how COVID-19 is impacting the global health R&D sector. Based on qualitative interviews, it looks at both immediate impacts, including disruptions to research and diversion of funding and expertise, as well as long-term challenges and opportunities that may reshape the sector in the years to come.

Learn more

Member Spotlight: DSW

Deutsche Stiftung Weltbevölkerung (DSW) is a global development organization that focuses on the needs and potential of the largest youth generation in history. In a recent article published by the African Academy of Sciences, DSW and the Alliance for Accelerating Excellence in Science in Africa outline the importance of AU-EU leadership for global health R&I cooperation.

View article

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Members
0
Members
Health Technologies in Development by Members
0
Health Technologies in Development by Members
Countries where Members Work
0
Countries where Members Work
Donor Governments Supporting Member Projects
0
Donor Governments Supporting Member Projects

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn More
GHTC delivers statement on antimicrobial resistance at WHO Executive Board meeting
PATH/Gabe Bienczycki
January 25, 2021

GHTC delivers statement on antimicrobial resistance at WHO Executive Board meeting

GHTC delivered a statement at the 148th session of the World Health Organization (WHO) Executive Board calling on WHO and member states to increase investment in R&D for affordable and accessible health technologies to fight antimicrobial resistance (AMR). The statement, issued through the Global Health Council, urges WHO and member states to advance policies and incentives to revitalize the fragile research pipeline, including supporting the Global Antibiotic Research and Development Partnership.

Learn more
GHTC submits statement on global immunization strategy to WHO Executive Board
PATH/Patrick McKern
January 25, 2021

GHTC submits statement on global immunization strategy to WHO Executive Board

GHTC submitted a statement to the 148th session of the World Health Organization (WHO) Executive Board commending WHO and member states on achieving progress toward global immunization targets and calling for greater investment in R&D for vaccine technologies and capacity-building for vaccine uptake, noting continued gaps in coverage. The statement, issued through the Global Health Council, calls on WHO and member states to address the full spectrum of immunization innovations, from administration to storage to service delivery.

Learn more
GHTC delivers statement on global strategy on health, innovation, and IP at WHO Executive Board meeting
PATH/Gabe Bienczycki
January 22, 2021

GHTC delivers statement on global strategy on health, innovation, and IP at WHO Executive Board meeting

GHTC delivered a statement at the 148th session of the World Health Organization (WHO) Executive Board calling on WHO to address leading barriers to innovation of and access to essential health products. The statement, issued through the Global Health Council, urges WHO and member states to bolster regulatory capacity and harmonization, strengthen the Global Observatory on Health Research and Development, develop target product profiles for needed tools, and expand the Essential Diagnostics List as part of this effort.

Learn more
View all News
View all Events
View all Breakthroughs Blog
Our Members work to improve health worldwide